NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Paragon Genomics

Paragon Genomics

Private
Fremont, CaliforniaHealthcare & Life Scienceshttps://paragongenomics.com/

Last Round

Series A

Sep 12, 2017

Total Funding Raised

$8M

Company Overview

Paragon Genomics is a life science company that develops and commercializes advanced target enrichment and library preparation solutions for Next-Generation Sequencing (NGS).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

next-generation sequencingNGSlibrary preparationmultiplex PCRtargeted sequencingamplicon sequencingNGS library prepcustom NGS panelsgenomic analysisbiotech reagentsmolecular diagnosticsassay designlife sciences toolsviral surveillance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Paragon Genomics Comps

Public and private peers based on sector, stage, and business model.

Paragon Genomics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Paragon Genomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 12, 2017

Key People

Founding team and executive leadership

Tao Chen

CEO and Co-Founder

Founding Team

Paragon Genomics Investors

Notable investors and investment history

Paragon Genomics investors
InvestorRounds
Heda VenturesSeries A
Cloudstone CapitalSeries A
HEDA VenturesSeries A
Cowin CapitalSeries A
Wisemont CapitalSeries A

Paragon Genomics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Paragon Genomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Paragon Genomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersFremont, California
Employee Range17
Year Founded2015
Last FundingSep 12, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.